Bridging Gaps in the AL-Amyloidosis Patient Pathway

In collaboration with expert panelists, researchers, and advocacy organizations, the American Heart Association (AHA) is advancing a nationwide initiative to identify and address critical gaps across the AL-Amyloidosis care continuum—ensuring earlier diagnosis, timely referrals to specialized care, and comprehensive patient support throughout the journey.